← Open Payments lookup

VERONICA SPANDLER: Open Payments

NPI 1023626314 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$421 in 14 payments from 7 companies in 2025. Trend: 2023 $434 · 2024 $566 · 2025 $421

Food & beverage: $421
CompanyPaymentsAmount
Eisai Inc.3$140
AstraZeneca Pharmaceuticals LP4$87
Merck Sharp & Dohme LLC2$69
ARRAY BIOPHARMA INC2$50
ADC THERAPEUTICS AMERICA, INC.1$34
Daiichi Sankyo Inc.1$21
Novartis Pharmaceuticals Corporation1$20

Products named: Lenvima, KEYTRUDA, BRAFTOVI, ZYNLONTA, LYNPARZA, DATROWAY, KISQALI, TAGRISSO.

Industry payments across CA — which companies pay providers there.